UNSPSC 85491903: Restriction of thoracic aorta with extraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of thoracic aorta with extraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02VW4CZ

UNSPSC 85491903 Restriction of thoracic aorta with extraluminal device, percutaneous endoscopic approach is a Commodity code that carries a medical-procedure taxonomy designation but does not align with the state and local procurement activity currently tagged under it. The recent opportunities posted against this code include independent medical evaluation services for pension disability determinations, surgical benefit carve-out programs for employee health plans, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve thoracic aorta procedures, extraluminal devices, or percutaneous endoscopic approaches. The code shows a fundamental classification mismatch between its procedural specificity and the generalized healthcare administration and staffing services actually being solicited.

The issuing bodies across these opportunities span county health systems (Santa Clara County Health System), county probation and human services agencies (Harris County Juvenile Probation Department, Collier County Board of County Commissioners), state transportation departments (Washington State Department of Transportation), and municipal retirement offices (City of Phoenix Retirement Office). Recent solicitations include Phoenix's RFP for independent medical evaluation services due October 16, 2026, Long Beach's RFP for surgical benefit carve-out programs due October 7, 2026, and Washington State Ferries' occupational medical surveillance RFP due October 9, 2026. Activity is concentrated in California, Arizona, Washington, and Florida, with no recent opportunities in this code reflecting actual thoracic aorta device restriction procedures or the clinical supply chain such activity would require.